INVO Bioscience Inc. (INVO) - הון עצמי של החברה

INVO Bioscience, Inc. (INVO) offers an innovative method for in vivo embryo maturation, making infertility treatment more accessible. The company is expanding its network of clinic partnerships to implement INVOcell systems, thereby optimizing IVF costs. The business is currently revising its strategy to move away from narrow specialization through a merger with a medical center operator, while the indicator stands at -0.01. The asset's market dynamics are presented below.

For INVO Bioscience, Inc. (INVO), which automates incubation in reproductive medicine, book capitalization dynamics serve as an indicator of the real value of net assets minus liabilities. Daily recalculations of market data consensus allow investors to track hardware system depreciation and the efficiency of technology capitalization, where a high margin of safety minimizes shock risks but may limit overall investment returns.